Are you a patient or caregiver?
Check out resources for discussion with your health care provider. Follow research and advocacy efforts on Twitter: @deprescribing for deprescribing.org and @DeprescribeNet for the Canadian Deprescribing Network.
Patients have an important role in advocating for improving medication use through deprescribing. If you are interested in sharing your story, or taking part in surveys, focus groups or interviews, or just finding out what is going on with public deprescribing education in Canada, contact the Canadian Deprescribing Network at email@example.com.
Please note that we cannot offer advice regarding individual health issues. Please talk to your own health care provider.
Are you a health care provider?
If you’re a health care provider viewing deprescribing.org, then you’ve already got some ideas about what needs to change in the way we manage medications for the elderly. We hope you’ll use the resources on this website, or let us know about ones you’ve found helpful so that we can share them. Consider joining CaDeN, signing up for a newsletter, or getting in touch if you have an interest in collaborating or participating in research at firstname.lastname@example.org.
“More than 90% of patients are willing to stop a medication if their doctor says it is possible”
Are you an educator or researcher?
Join the deprescribing conversation by commenting on our research or sharing your own research on Twitter or ResearchGate. By sharing research progress, we can better understand the impact of deprescribing and how to best approach it safely and effectively.These proceedings papers, developed as a result of the March 2018 Ottawa symposium, outline progress in deprescribing implementation and research.
Consider ways to include polypharmacy and deprescribing content into both undergraduate and continuing education curricula. Check out this paper highlighting conversations about deprescribing education from the March 2018 Ottawa symposium.
Use our methods and instruction manual to develop more evidence-based deprescribing guidelines. Or, plan to incorporate deprescribing recommendations into clinical practice guidelines. The manual provides step-by-step instructions for developing a new evidence-based deprescribing guideline. It covers the activities involved in coordinating the development of such guidelines and provides insights into the workload, activities, and time involved in the process in order to establish accurate timelines and budgets.
Please contact us if you want to collaborate by implementing and evaluating one of the Bruyère Research Team’s deprescribing guidelines, or simply let us know about your research or educational initiative: email@example.com
“The guideline is great because it reinforces the way I practice. I feel better about what I’m doing and why I’m doing it. It is helpful to know that my colleagues agree and that there’s written literature to support me.”